Eupraxia Virtually Opens The Market

TORONTO , March 19, 2021 /CNW/ - James Helliwell , President and Chief Executive Officer, Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), and his team joined Dani Lipkin , Director, Global Business Development, TMX Group to celebrate the Company's new listing on Toronto Stock Exchange and open the market.

Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to currently approved drugs. Each of Eupraxia's product candidates has the potential to address therapeutic areas with high unmet medical need, and strives to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. For more information visit: https://eupraxiapharma.com

For Market Openings: Media may pick up a feed from the TOC (television operations centre) for all market open ceremonies. The feed is named TSX Transmit 1 (SD-SDI) and is produced at the TMX Broadcast Centre and sent live to the TOC. To pick up the feed via the Dejero network, please contact avservices@tmx.com . The client feature video will begin playing on the TMX media wall at approximately 9:27 a.m. ET and the markets will open with the sound of a siren at 9:30 a.m. ET

Date: Friday, March 19, 2021
Time:   9: 00am - 9:30am
Place:  Virtually Broadcast

SOURCE Toronto Stock Exchange

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2021/19/c0454.html